These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32061944)

  • 1. Feasibility and clinical utility of a pan-solid tumor targeted RNA fusion panel: A single center experience.
    Hindi I; Shen G; Tan Q; Cotzia P; Snuderl M; Feng X; Jour G
    Exp Mol Pathol; 2020 Jun; 114():104403. PubMed ID: 32061944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Clinical Validation of a Large Fusion Gene Panel for Pediatric Cancers.
    Chang F; Lin F; Cao K; Surrey LF; Aplenc R; Bagatell R; Resnick AC; Santi M; Storm PB; Tasian SK; Waanders AJ; Hunger SP; Li MM
    J Mol Diagn; 2019 Sep; 21(5):873-883. PubMed ID: 31255796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing.
    Guseva NV; Tanas MR; Stence AA; Sompallae R; Schade JC; Bossler AD; Bellizzi AM; Ma D
    Cancer Genet; 2016; 209(7-8):303-12. PubMed ID: 27292373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic Isoforms.
    Sussman RT; Oran AR; Paolillo C; Lieberman D; Morrissette JJD; Rosenbaum JN
    Arch Pathol Lab Med; 2020 Jan; 144(1):90-98. PubMed ID: 31211614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anchored multiplex PCR for targeted next-generation sequencing reveals recurrent and novel USP6 fusions and upregulation of USP6 expression in aneurysmal bone cyst.
    Guseva NV; Jaber O; Tanas MR; Stence AA; Sompallae R; Schade J; Fillman AN; Miller BJ; Bossler AD; Ma D
    Genes Chromosomes Cancer; 2017 Apr; 56(4):266-277. PubMed ID: 27910166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of RNA-Based Next-Generation Sequencing Assays for the Detection of NTRK Gene Fusions.
    Park HJ; Baek I; Cheang G; Solomon JP; Song W
    J Mol Diagn; 2021 Nov; 23(11):1443-1451. PubMed ID: 34756276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens.
    Haley L; Parimi V; Jiang L; Pallavajjala A; Hardy M; Yonescu R; Morsberger L; Stinnett V; Long P; Zou YS; Gocke CD
    J Mol Diagn; 2021 Oct; 23(10):1343-1358. PubMed ID: 34358677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing.
    Beadling C; Wald AI; Warrick A; Neff TL; Zhong S; Nikiforov YE; Corless CL; Nikiforova MN
    J Mol Diagn; 2016 Mar; 18(2):165-75. PubMed ID: 26747586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing.
    Seager M; Aisner DL; Davies KD
    J Vis Exp; 2019 Jul; (149):. PubMed ID: 31329176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study.
    Vaughn CP; Costa JL; Feilotter HE; Petraroli R; Bagai V; Rachiglio AM; Marino FZ; Tops B; Kurth HM; Sakai K; Mafficini A; Bastien RRL; Reiman A; Le Corre D; Boag A; Crocker S; Bihl M; Hirschmann A; Scarpa A; Machado JC; Blons H; Sheils O; Bramlett K; Ligtenberg MJL; Cree IA; Normanno N; Nishio K; Laurent-Puig P
    BMC Cancer; 2018 Aug; 18(1):828. PubMed ID: 30115026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Performance Comparison of Commonly Used Assays to Detect RET Fusions.
    Yang SR; Aypar U; Rosen EY; Mata DA; Benayed R; Mullaney K; Jayakumaran G; Zhang Y; Frosina D; Drilon A; Ladanyi M; Jungbluth AA; Rekhtman N; Hechtman JF
    Clin Cancer Res; 2021 Mar; 27(5):1316-1328. PubMed ID: 33272981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting disease-defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next-generation sequencing-Molecular and clinicopathological characterization of 16 cases.
    Mantilla JG; Ricciotti RW; Chen E; Hoch BL; Liu YJ
    Genes Chromosomes Cancer; 2019 Oct; 58(10):713-722. PubMed ID: 31033080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Validation of FusionPlex RNA Sequencing and Its Utility in the Diagnosis and Classification of Hematologic Neoplasms.
    Chen X; Wang W; Yeh J; Wu Y; Oehler VG; Naresh KN; Liu YJ
    J Mol Diagn; 2023 Dec; 25(12):932-944. PubMed ID: 37813298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation Sequencing.
    Lam SW; Cleton-Jansen AM; Cleven AHG; Ruano D; van Wezel T; Szuhai K; Bovée JVMG
    J Mol Diagn; 2018 Sep; 20(5):653-663. PubMed ID: 30139549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of Bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal Bone Cysts.
    Dermawan JK; Cheng YW; Tu ZJ; Meyer A; Habeeb O; Zou Y; Goldblum JR; Billings SD; Kilpatrick SE; Reith JD; Shurtleff SA; Farkas DH; Rubin BP; Azzato EM
    Arch Pathol Lab Med; 2021 Jul; 145(7):851-863. PubMed ID: 33147323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays.
    Pfarr N; Kirchner M; Lehmann U; Leichsenring J; Merkelbach-Bruse S; Glade J; Hummel M; Stögbauer F; Lehmann A; Trautmann M; Kumbrink J; Jung A; Dietmaier W; Endris V; Kazdal D; Evert M; Horst D; Kreipe H; Kirchner T; Wardelmann E; Lassen U; Büttner R; Weichert W; Dietel M; Schirmacher P; Stenzinger A
    Genes Chromosomes Cancer; 2020 Mar; 59(3):178-188. PubMed ID: 31652375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of sarcoma fusions by a next-generation sequencing based-ligation-dependent multiplex RT-PCR assay.
    Lanic MD; Le Loarer F; Rainville V; Sater V; Viennot M; Beaussire L; Viailly PJ; Angot E; Hostein I; Jardin F; Ruminy P; Laé M
    Mod Pathol; 2022 May; 35(5):649-663. PubMed ID: 35075283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors.
    Luthra R; Patel KP; Routbort MJ; Broaddus RR; Yau J; Simien C; Chen W; Hatfield DZ; Medeiros LJ; Singh RR
    J Mol Diagn; 2017 Mar; 19(2):255-264. PubMed ID: 28017569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors.
    Reeser JW; Martin D; Miya J; Kautto EA; Lyon E; Zhu E; Wing MR; Smith A; Reeder M; Samorodnitsky E; Parks H; Naik KR; Gozgit J; Nowacki N; Davies KD; Varella-Garcia M; Yu L; Freud AG; Coleman J; Aisner DL; Roychowdhury S
    J Mol Diagn; 2017 Sep; 19(5):682-696. PubMed ID: 28802831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods.
    Su D; Zhang D; Chen K; Lu J; Wu J; Cao X; Ying L; Jin Q; Ye Y; Xie Z; Xiong L; Mao W; Li F
    J Exp Clin Cancer Res; 2017 Sep; 36(1):121. PubMed ID: 28882180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.